Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vaccines for plague

A plague and vaccine technology, applied in biochemical equipment and methods, antibody mimics/scaffolds, bacterial antigen components, etc., can solve problems that are not suitable for large-scale immunization

Inactive Publication Date: 2004-06-30
THE SEC OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTYS GOVERNMENT OF THE UK OF GREAT BRITAIN & NORTHERN IRELAND
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the West, this vaccine is considered unsuitable for mass immunization due to its very serious side effects and the possibility of toxic reversion

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vaccines for plague
  • Vaccines for plague

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0157] Example 1: To construct a DNA vaccine expressing V antigen, the vector plasmid pCMV was digested with restriction endonuclease Not 1 to remove the coding sequence of the Lac Z gene. The digested plasmid is treated with Klenow enzyme to generate blunt-ended vector DNA. The ssp1 restriction fragment containing the fusion protein coding sequence of V antigen and glutathione S transferase was isolated from the recombinant plasmid pVG100 and ligated with the vector DNA. The V sequence used here is the sequence described in Example Seq ID No 3. The recombinant plasmid was transformed into Escherichia coli Nova Blue, and the purified plasmid was inoculated into Balb / c mice by intramuscular injection. Immunoglobulin responses to the V antigen were detected in the sera of vaccinated animals.

Embodiment 2

[0158] Example 2: In order to construct a DNA vaccine expressing F1 antigen, PCR primers were designed to amplify the full-length caf 1 open reading frame. This reading frame encodes the signal peptide for the secretion of F1 and the leader protein from bacterial cells. The PCR primers used have a "tail" containing a restriction enzyme recognition site at their 5' end, allowing the amplified product to be directly inserted into the vector plasmid. The sequences of PCR primers 5'FAB2 and 3'FBAM are shown in Seq ID No 18 and Seq ID No 19, respectively.

[0159]Using 5'FAB2 and 3'FBAM to amplify a PCR fragment, the sequence of this PCR fragment is shown in Seq ID no 20. This PCR fragment was digested with restriction enzymes NheI and BamHI and cloned into pBKCMV plasmid digested with the same enzymes. The resulting recombinant plasmid pFlAB was transformed into Escherichia coli Nova Blue, and the purified plasmid was inoculated into Bal b / c mice by intramuscular injection. Imm...

Embodiment 3

[0160] Example 3: In order to construct a DNA vaccine expressing F1 and V simultaneously, the V antigen coding sequence was inserted into the DNA vaccine expressing F1 introduced in Example 2. There is a connecting region encoding 6 amino acids between the coding sequences of F1 and V, so that the two proteins can independently form their respective configurations. The sequence encoding the junction region-V was obtained by digesting the recombinant plasmid placFV6 with BamHI and HindIII, and the sequence encoding the junction region-V was ligated with the plasmid pFIAB digested with the same restriction enzymes. The resulting plasmid pFVAB was transformed into E. coli Nova Blue. Plasmids were purified for later use. See Seq ID No 22 for the fused F1 / V sequence and deduced amino acid sequence.

[0161] Examples of fusion proteins containing F1 and V antigens are described below.

[0162] Enzymes and Reagents

[0163] Materials used to prepare media were obtained from Oxoid...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

A method of protecting a human or animal body from the effects of infection with Y. pestis is provided comprising administering to the body a vaccine including Yersinia pestis V antigen and Yersinia pestis F1 antigens or a protective epitopic part of each of these in a form other than whole Y. Pestis organisms. Preferably the antigens are administered in the form of a live vaccine or as recombinantly produced isolated and / or purified proteins. DNA encoding the whole or part of the F1 antigen and DNA encoding the whole or part of the V antigen may be used directly as a genetic vaccine.

Description

technical field [0001] The present invention relates to novel protective vaccines against infection by Yersinia pestis and methods of administering these vaccines. The invention particularly provides parenterally administered active vaccines and orally administered active vaccines which confer protection against bubonic and pneumonic plague. In particular mucosal immunity is induced in humans and animals by these vaccines. Background technique [0002] Yersinia pestis is a highly virulent pathogenic microorganism that causes plague in a variety of animals, including humans. Infection with this microorganism has a high mortality rate. Studies have shown that its strong toxicity is determined by a complex combination of factors encoded by chromosomes and three plasmids, including Lcr gene, fibrinolytic enzyme and capsule. [0003] Humans are an occasional host in the natural cycle of the disease, and bubonic plague can occur following the bite of an infected flea and is cha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/09A61K39/00A61K39/07A61P31/04A61P31/12C07K14/24C12N15/31
CPCC07K2319/00C07K14/24A61K39/00A61P31/04A61P31/12A61P37/04Y02A50/30
Inventor R·W·蒂巴尔E·D·维利尔姆森S·E·C·莱里P·C·F·奥斯顿A·M·奔内特
Owner THE SEC OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTYS GOVERNMENT OF THE UK OF GREAT BRITAIN & NORTHERN IRELAND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com